Biomoda Inc. Outsources to Seattle's PhenoPath for Cancer Diagnostic Development.ALBUQUERQUE, N.M. -- PhenoPath contract part of multistep plan to collaborate with established diagnostic organizations Biomoda Inc. has contracted with PhenoPath Laboratories, PLLC PLLC Professional Limited Liability Company PLLC Polk Life and Learning Center (Bartow, FL) PLLC Partners of Limited Liability Corporation , www.phenopath.com, a research and development pathology laboratory in Seattle. PhenoPath will support Biomoda's diagnostic development program for early detection and treatment of cancers, primarily lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . PhenoPath is a widely respected and highly experienced laboratory organization with particular skills and expertise in pathology and biomarker development and applications. In the past eight months Biomoda has entered into numerous relationships in order to expedite and further perfect its patented and proprietary developments for regulatory approval, accelerated commercialization and market acceptance. Among these organizations with whom Biomoda is working are: Esocor LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , JR Associates, Majestic Sarl, Triangulum Consulting Services Noun 1. consulting service - service provided by a professional advisor (e.g., a lawyer or doctor or CPA etc.) service - work done by one person or group that benefits another; "budget separately for goods and services" Inc. and TriCore Reference Laboratories. PhenoPath Laboratories, PLLC is a significant element to this strategy. Biomoda Inc., a development stage in-vitro diagnostics organization, is focused on research, development and commercialization of cancer diagnostics. The company, exclusive worldwide licensee from the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). of several patents developed for noninvasive early detection and treatment of lung cancer, is in the process of registering additional patents in this area. The company's proprietary technologies provide minimally invasive and minimal impact approaches as cancer diagnostic products. Operating from its laboratory situated at Kirtland Air Force Base Kirtland Air Force Base is located in the southeast quadrant of Albuquerque, New Mexico, adjacent to the Albuquerque International Sunport. The base is the third largest installation in Air Force Materiel Command, covering 51,558 acres (209 km²) and employing over 23,000 people, (Albuquerque, N.M.), the company is in the process of expanding and expediting its product development and commercialization with a number of strategic alliances that will be announced over the next 60 days. This news release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates" and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . For additional information, visit the Biomoda Web site at www.biomoda.com or call us at 505-821-0875. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion